Physician Profile
Inaganti M. Shah, M.D. is a healthcare provider in Omaha, NE specializing in hematology/oncology. Inaganti is also listed as specializing in hematology & oncology. According to Medicare claims data, Inaganti cared for 1,857 Medicare patients across 151,611 services. The services billed most often include injection, darbepoetin alfa, 1 microgram (non-esrd use), injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram, and injection, nivolumab, 1 mg. This provider record is associated with NPI 1295829042.
Factual summary compiled by Guide.md from public records; not written by this provider.
Exactly as CMS reports it (National Downloadable File, Opt-Out Affidavits, Order & Referring). Not an insurance directory; confirm coverage with the office.
6901 N 72ND ST SUITE 2244
Omaha, NE 68122
Within Hematology and Oncology generally. Availability varies by clinician, training and location — this profile has not been claimed, so nothing here is a personal claim by the provider.
Most searched conditions
Advanced Cancers
Blood & Lymph Disorders
Blood Cancers
Blood Disorders
Blood disorders
Bone & Soft Tissue Cancers
Digestive Cancers
Endocrine Cancers
Endocrine tumors
Gastrointestinal cancer
General oncology
Genetic Blood Disorders
Gynecologic cancer
Gynecologic Cancers
Head & Neck Cancers
Head and neck cancer
Neurologic Cancers
Oncologic emergencies
Ophthalmologic oncology
Skin cancer
Skin Cancers
Urologic Cancers
Most searched procedures
Biopsies & Diagnostics
Blood disorder care
Cancer Therapies
Cancer therapy
Cellular Therapies
Consultations
Diagnostic testing
Hematology Treatments
Imaging
Infusions
Interventional oncology
Supportive Cancer Care
Supportive cancer care
Surgical & Vascular Access
Testing & Genetics
Vascular access care
151,611 services · 1,857 patients · 25 distinct codes
| Procedure | Type | Code | Services | Compared with peers |
|---|---|---|---|---|
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Treatment | 96367 |
510 | More than most peers in Hematology/Oncology |
| Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Drug given | J0881 |
39,295 | More often than most peers in Hematology/Oncology |
| Injection, nivolumab, 1 mg | Drug given | J9299 |
14,460 | As often as other peers in Hematology/Oncology |
| Injection, oxaliplatin, 0.5 mg | Drug given | J9263 |
13,100 | As often as other peers in Hematology/Oncology |
| Injection, pembrolizumab, 1 mg | Drug given | J9271 |
11,400 | As often as other peers in Hematology/Oncology |
| Injection, aprepitant, 1 mg | Drug given | J0185 |
8,840 | As often as other peers in Hematology/Oncology |
| Injection, denosumab, 1 mg | Drug given | J0897 |
8,280 | More often than most peers in Hematology/Oncology |
| Injection, daratumumab, 10 mg and hyaluronidase-fihj | Drug given | J9144 |
5,400 | Less often than most peers in Hematology/Oncology |
| Injection, paclitaxel, 1 mg | Drug given | J9267 |
5,291 | As often as other peers in Hematology/Oncology |
| Injection, ferric derisomaltose, 10 mg | Drug given | J1437 |
4,900 | More often than most peers in Hematology/Oncology |
Source: CMS Medicare public data. Shows how often procedures were billed — not quality of care or patient satisfaction.
Inaganti M. Shah is a hematology/oncology in Omaha, NE. That is the designation recorded for this NPI in the federal registry.
NPI registry
Inaganti M. Shah is listed at 6901 N 72Nd St Suite 2244, Omaha, NE 68122. Addresses come from the NPI registry and can lag a move, so confirm before travelling.
NPI registry
The number on file is (402) 572-3535. Contact the office directly to confirm availability and scheduling.
NPI registry
Inaganti M. Shah's National Provider Identifier is 1295829042. It is issued by the Centers for Medicare & Medicaid Services and is unique and permanent — it does not change if they move practice.
NPI registry
Inaganti M. Shah attended Other, graduating in 1988. This comes from the CMS National Downloadable File.
CMS public data
Inaganti M. Shah has 38 years experience. Calculated from a graduation year of 1988, reported in the CMS National Downloadable File.
CMS public data
According to Medicare billing data, Inaganti M. Shah provides treatments such as infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less, alongside routine visits and testing. This reflects Medicare patients only and is billing volume, not a measure of quality.
Medicare claims
Not yet. This profile is built from public federal data and has not been confirmed by Inaganti M. Shah. If this is you, claiming it is free.
Guide.md
Guide.md listings do not constitute medical advice or an endorsement.